SQZ Biotechnologies Co
OTC:SQZB
Cash Flow Statement
Cash Flow Statement
SQZ Biotechnologies Co
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
(51)
|
(51)
|
(66)
|
(64)
|
(75)
|
(69)
|
(74)
|
(78)
|
(78)
|
(79)
|
(76)
|
(71)
|
(72)
|
|
| Depreciation & Amortization |
2
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
|
| Stock-Based Compensation |
1
|
4
|
4
|
6
|
4
|
9
|
5
|
6
|
9
|
8
|
7
|
6
|
5
|
|
| Other Non-Cash Items |
13
|
13
|
17
|
15
|
17
|
18
|
19
|
19
|
19
|
19
|
18
|
16
|
20
|
|
| Change in Working Capital |
(12)
|
(7)
|
(17)
|
(27)
|
(24)
|
(33)
|
(28)
|
(26)
|
(26)
|
(24)
|
(30)
|
(28)
|
(25)
|
|
| Cash from Operating Activities |
(48)
N/A
|
(43)
+10%
|
(64)
-48%
|
(75)
-17%
|
(80)
-8%
|
(82)
-2%
|
(82)
+0%
|
(83)
-1%
|
(84)
-1%
|
(84)
+0%
|
(87)
-4%
|
(82)
+6%
|
(74)
+9%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
50
|
59
|
0
|
16
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
48
N/A
|
58
+21%
|
58
0%
|
15
-74%
|
7
-52%
|
(1)
N/A
|
(1)
+10%
|
(0)
+35%
|
(0)
-8%
|
(0)
-26%
|
(0)
+24%
|
(0)
+51%
|
(0)
+78%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
68
|
118
|
175
|
133
|
133
|
1
|
(55)
|
(53)
|
(52)
|
4
|
4
|
1
|
0
|
|
| Other |
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
55
|
56
|
56
|
56
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
68
N/A
|
116
+72%
|
172
+48%
|
130
-24%
|
130
+0%
|
56
-57%
|
1
-99%
|
4
+581%
|
4
+14%
|
4
+1%
|
4
-1%
|
1
-76%
|
0
-67%
|
|
| Change in Cash | ||||||||||||||
| Net Change in Cash |
68
N/A
|
131
+94%
|
166
+26%
|
70
-57%
|
57
-19%
|
(27)
N/A
|
(82)
-206%
|
(80)
+3%
|
(80)
-1%
|
(80)
+0%
|
(83)
-4%
|
(81)
+3%
|
(74)
+8%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(50)
N/A
|
(44)
+11%
|
(65)
-47%
|
(75)
-16%
|
(81)
-8%
|
(83)
-2%
|
(83)
+0%
|
(83)
-1%
|
(84)
-1%
|
(84)
+0%
|
(87)
-4%
|
(82)
+6%
|
(75)
+9%
|
|